COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
Supporting Files
Public Domain
-
July 01 2020
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.
-
Subjects:
-
Source:Emerg Infect Dis. 26(10):2513-2515
-
Pubmed ID:32609083
-
Pubmed Central ID:PMC7510728
-
Document Type:
-
Genre:
-
Place as Subject:
-
Volume:26
-
Issue:10
-
Collection(s):
-
Main Document Checksum:urn:sha256:7389d7e41b2ea1ba002945086c60bff55cdd8a7175e672edc6f046b185e1a930
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases